Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1060592

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many weeks’ worth of medicines the Government has asked pharmaceutical companies to stockpile as part of preparations for the UK leaving the EU without a deal; and how his Department decided on that period of duration.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	220998
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 221000 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
tabling member	4610 label Biography information for Bambos Charalambous

1060594

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what information he holds on those NHS breast cancer drugs that pharmaceutical companies will have six weeks' supply of by 29 March 2019.
tabling member constituency	Enfield, Southgate
tabling member printed	Bambos Charalambous
uin	221000
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>We understand that breast cancer drugs are vitally important to many people in this country. Our ‘no deal’ European Union exit contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/European Economic Area (EEA), to ensure that the supply of breast cancer drugs and other essential medicines to patients is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from or via the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019 in a ‘no deal’ scenario. The duration of the stockpiling requirement was based on the Government’s reasonable worst-case scenario border disruption planning assumptions.</p><p> </p><p>We also recognise that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of the no deal exit.</p><p> </p><p>The Department is unable to discuss specific medicines because to we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme, in order to reassure participating companies. This means not introducing information about a specific company, medicine, or a supply route into the public domain or to a third party.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220998 question first answered 18/02/2019 15:19:26 answering member 1585 label Biography information for Stephen Hammond
tabling member	4610 label Biography information for Bambos Charalambous

1060618

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Brexit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the cost to the public purse of his Department's preparations for the UK leaving the EU without a deal.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	220768
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Of the £71.1 million funding the Department has been allocated for 2018/19 and 2019/20 for preparations for European Union exit, we are unable to provide a breakdown of the amount of funding allocated to ‘no deal’ preparations specifically, as this cannot be separated from EU exit work as a whole across the Department.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:21:35 answering member 1585 label Biography information for Stephen Hammond
tabling member	308 label Biography information for Mr Jim Cunningham

1060620

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, what advice he has for people on kidney dialysis who wish to travel in the EU or EEA and to whom his advice of 28 January 2019 does not cover because dialysis is not covered under travel insurance.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220902
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220903 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott

1060621

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the advice issued on 28 January 2019 entitled New advice for travellers visiting the UK, European Union or European Economic Area in the event of a no-deal EU exit, when he will issue an update to that advice for people on kidney dialysis who wish to travel to the EU or EEA.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220903
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220902 220904 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott

1060622

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what advice he has on compensation to people on dialysis who book, or who have already booked, travel to the EU or EEA and who have to cancel it because they are unable to secure State-funded dialysis treatment whilst they are away.
tabling member constituency	Sunderland Central
tabling member printed	Julie Elliott
uin	220904
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>If the United Kingdom leaves the European Union without a deal, the Department cannot guarantee the European Health Insurance Card (EHIC) will be valid after 29 March 2019 in all European Economic Area countries.</p><p> </p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover.</p><p> </p><p>People requiring dialysis treatment when travelling should always seek advice from their doctor and renal unit before booking travel. They should also contact the chosen dialysis administrator at the destination of travel to ensure their treatment is covered after 29 March 2019 in a ‘no-deal’ scenario and so that they are aware of and can agree to any potential charges before booking travel.</p><p> </p><p>Healthcare advice on the National Health Service for travellers with pre-existing conditions including dialysis users is being updated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond grouped question UIN 220902 220903 question first answered 18/02/2019 15:22:51 answering member 1585 label Biography information for Stephen Hammond
tabling member	4127 label Biography information for Julie Elliott

1060643

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the UK leaving the EU on 29 March 2019 on the supply of medicines to the UK for NHS use.
tabling member constituency	Cardiff West
tabling member printed	Kevin Brennan
uin	220816
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Our number one priority is to ensure patients continue to have unhindered access to medicines as we exit the European Union and we are working with all sectors in the supply chain to ensure this happens.</p><p> </p><p>The Government remains committed to leaving the EU with a deal. Under the conditions of the Withdrawal Agreement, there will be a two-year Implementation Period within which the Government will negotiate the United Kingdom’s future relationship with the EU. During the Implementation Period, there will be no change to the current trading arrangements with the EU/European Economic Area (EEA), meaning the supply of medicines and medical products will continue unhindered.</p><p> </p><p>As a responsible Government, we are planning for all possible exit scenarios, including ‘no deal’. Our ‘no deal’ medicines supply contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the EU/ EEA to ensure that the supply of essential medicines, is not disrupted.</p><p> </p><p>In August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU/EEA asking them to ensure a minimum of six weeks additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. The response from industry has been very positive. The vast majority of companies have confirmed stockpiling plans are in place.</p><p> </p><p>On 7 December, the Government published updated reasonable worst-case scenario border disruption planning assumptions in the event of a ‘no deal’ EU exit. Medicines and medical products are prioritised in cross-Government planning, and the Department is working with relevant partners across Government and industry to ensure we have sufficient roll-on, roll-off freight capacity on alternative routes to enable these vital products to continue to move freely into the UK.</p><p> </p><p>We are confident that if everyone does what they need to do, supplies will continue unhindered. The Department does not expect to see significant changes to existing medicine supply chains or capacity in the intervening period between now and 29 March 2019, although we will be monitoring this closely.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:10:21 answering member 1585 label Biography information for Stephen Hammond
tabling member	1400 label Biography information for Kevin Brennan

1060724

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: British Nationals Abroad
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what arrangements will be in place to provide healthcare cover for UK state pensioners who reside in the EU after the UK leaves the EU.
tabling member constituency	Hove
tabling member printed	Peter Kyle
uin	220982
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>The United Kingdom Government appreciates the importance of retaining reciprocal healthcare arrangements with the European Union, and has been clear in the negotiations that it wants to protect the rights of UK citizens in the EU.</p><p>Subject to the Withdrawal Agreement being agreed by Parliament, during the implementation period the current rules on reciprocal healthcare will continue until December 2020. The rights of UK nationals living in the EU, and who fall within the scope of the Withdrawal Agreement, will continue to be protected after December 2020, for as long as these individuals remain in scope of the Withdrawal Agreement. This includes state pensioners already benefiting from that cover.</p><p>The reciprocal healthcare system requires reciprocity from the EU or individual Member States and cannot be protected unilaterally. The UK Government is seeking agreements with Member States, so that no individual will face sudden changes to their healthcare cover in a ‘no deal’ scenario.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:18:09 answering member 1585 label Biography information for Stephen Hammond
tabling member	4505 label Biography information for Peter Kyle

1060783

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Professions: Regulation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what additional resources have been allocated to regulators of the health professions to support them with the potential increased workload of maintaining their registers in the event that the UK leaves the EU without a deal.
tabling member constituency	Sheffield Central
tabling member printed	Paul Blomfield
uin	220892
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>The Government has introduced legislation that will largely maintain existing arrangements for the recognition of European health and care qualifications. European qualifications that are currently recognised automatically by United Kingdom regulators (doctors, nurses, midwives, dentists and pharmacists), will continue to be recognised after the UK leaves the European Union. European qualifications that are not accepted automatically will continue to be assessed against the standard of UK qualifications, as is currently the case.</p><p> </p><p>UK regulators have been preparing for a possible 'no-deal' scenario. As the legislation introduced maintains the current systems as far as is possible for at least two years upon coming into force, little impact is expected after exit day. No additional funding has been allocated.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 15:20:41 answering member 1585 label Biography information for Stephen Hammond
tabling member	4058 label Biography information for Paul Blomfield

1060807

registered interest
date	13/02/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Training
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many nursing applications there were in each (a) constituent part of the UK and (b) (i) region of, (ii) local authority in and (iii) parliamentary constituency in England in each year from the 2015 to the 2019 cycle year.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	220908
answer	answer is ministerial correction date of answer 18/02/2019 answer text <p>Data on nursing applications is not held at local authority and parliamentary constituency level. Data on applications is not available for 2019 entry.</p><p> </p><p>The following table shows the number of applications made to nursing and midwifery courses in each United Kingdom nation.</p><p> </p><p>Number of applications to nursing and midwifery courses, split by UK country of provider and entry year</p><table><tbody><tr><td><p>Entry year</p></td><td><p>2015</p></td><td><p>2016</p></td><td><p>2017</p></td><td><p>2018</p></td></tr><tr><td><p>English providers</p></td><td><p>194,075</p></td><td><p>196,260</p></td><td><p>150,970</p></td><td><p>126,000</p></td></tr><tr><td><p>Northern Irish providers</p></td><td><p>7,220</p></td><td><p>7,330</p></td><td><p>6,750</p></td><td><p>6,325</p></td></tr><tr><td><p>Scottish providers</p></td><td><p>21,105</p></td><td><p>20,725</p></td><td><p>20,900</p></td><td><p>20,435</p></td></tr><tr><td><p>Welsh providers</p></td><td><p>9,885</p></td><td><p>10,445</p></td><td><p>9,490</p></td><td><p>9,810</p></td></tr></tbody></table><p>Source: Universities and Colleges Admissions Service (UCAS) published end of cycle data</p><p> </p><p>The following table shows the number of applications made to nursing and midwifery courses in each region of England.</p><p> </p><p>Number of applications to nursing and midwifery courses, split by English region of provider and entry year</p><table><tbody><tr><td><p>Entry year</p></td><td><p>2015</p></td><td><p>2016</p></td><td><p>2017</p></td><td><p>2018</p></td></tr><tr><td><p>East Midlands</p></td><td><p>15,045</p></td><td><p>15,620</p></td><td><p>11,620</p></td><td><p>9,490</p></td></tr><tr><td><p>East of England</p></td><td><p>16,450</p></td><td><p>16,775</p></td><td><p>12,455</p></td><td><p>9,390</p></td></tr><tr><td><p>London</p></td><td><p>45,520</p></td><td><p>46,415</p></td><td><p>33,490</p></td><td><p>27,775</p></td></tr><tr><td><p>North East</p></td><td><p>6,920</p></td><td><p>6,915</p></td><td><p>5,810</p></td><td><p>4,625</p></td></tr><tr><td><p>North West</p></td><td><p>32,220</p></td><td><p>32,100</p></td><td><p>26,095</p></td><td><p>22,510</p></td></tr><tr><td><p>South East</p></td><td><p>18,895</p></td><td><p>19,560</p></td><td><p>15,370</p></td><td><p>11,590</p></td></tr><tr><td><p>South West</p></td><td><p>10,050</p></td><td><p>10,790</p></td><td><p>8,415</p></td><td><p>7,395</p></td></tr><tr><td><p>West Midlands</p></td><td><p>23,240</p></td><td><p>23,200</p></td><td><p>17,550</p></td><td><p>14,915</p></td></tr><tr><td><p>Yorkshire and The Humber</p></td><td><p>22,045</p></td><td><p>20,820</p></td><td><p>17,120</p></td><td><p>14,865</p></td></tr></tbody></table><p>Source: UCAS unpublished end of cycle data</p><p> </p><p>Notes:</p><p>- Data on applications for 2019 entry is not held;</p><p> </p><p>- Each unique UCAS applicant can make up to five applications;</p><p> </p><p>- Refers to applications during the main UCAS application cycle. These do not include those made through clearing; and</p><p> </p><p>- These data do not include applications made directly to universities.</p><p> </p><p>There were 34,030 applicants from all domiciles to study nursing and midwifery at English providers at 15 January 2019 compared with 32,580 at the same time in 2018. This is an increase of 1,450, or 4.5%.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 18/02/2019 17:45:25 answering member 1585 label Biography information for Stephen Hammond
tabling member	4244 label Biography information for Jonathan Ashworth